Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.
CEO: Jay Flatley
Ticker symbol: ILMN
Headquarters: San Diego, CA
Number of employees: 3,750+ globally